研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2021 年的期刊文章 · 第 16 页
共 1542 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2021-06-21 到 2021-06-08。
按期刊、按主题看 →
JASA Spatial & Time Series High-Dimensional · 发表于 2021-06-21
Likai Chen, Weining Wang, Wei Biao Wu
摘要
For multiple change-points detection of high-dimensional time series, we provide asymptotic theory concerning the consistency and the asymptotic distribution of the breakpoint statistics and estimated break sizes. The theory backs up a simple two-step procedure for detecting and estimating multiple change-points. The proposed two-step procedure involves the maximum of a MOSUM (moving sum) type statistics in the first step and a CUSUM (cumulative sum) refinement step on an aggregated time series in the second step. Thus, for a fixed time-point, we can capture both the biggest break across different coordinates and aggregating simultaneous breaks over multiple coordinates. Extending the existing high-dimensional Gaussian approximation theorem to dependent data with jumps, the theory allows us to characterize the size and power of our multiple change-point test asymptotically. Moreover, we can make inferences on the breakpoints estimates when the break sizes are small. Our theoretical setup incorporates both weak temporal and strong or weak cross-sectional dependence and is suitable for heavy-tailed innovations. A robust long-run covariance matrix estimation is proposed, which can be of independent interest. An application on detecting structural changes of the U.S. unemployment rate is considered to illustrate the usefulness of our method. *(abstract via OpenAlex)*
JASA Causal Inference · 发表于 2021-06-21
Kosuke Imai, Michael Lingzhi Li
摘要
The increasing availability of individual-level data has led to numerous applications of individualized (or personalized) treatment rules (ITRs). Policy makers often wish to empirically evaluate ITRs and compare their relative performance before implementing them in a target population. We propose a new evaluation metric, the population average prescriptive effect (PAPE). The PAPE compares the performance of ITR with that of non-individualized treatment rule, which randomly treats the same proportion of units. Averaging the PAPE over a range of budget constraints yields our second evaluation metric, the area under the prescriptive effect curve (AUPEC). The AUPEC represents an overall performance measure for evaluation, like the area under the receiver and operating characteristic curve (AUROC) does for classification, and is a generalization of the QINI coefficient used in uplift modeling. We use Neyman’s repeated sampling framework to estimate the PAPE and AUPEC and derive their exact finite-sample variances based on random sampling of units and random assignment of treatment. We extend our methodology to a common setting, in which the same experimental data are used to both estimate and evaluate ITRs. In this case, our variance calculation incorporates the additional uncertainty due to random splits of data used for cross-validation. The proposed evaluation metrics can be estimated without requiring modeling assumptions, asymptotic approximation, or resampling methods. As a result, it is applicable to any ITR including those based on complex machine learning algorithms. The open-source software package is available for implementing the proposed methodology. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
JASA Testing & Uncertainty · 发表于 2021-06-21
Xin Xing, Zhigen Zhao, Jun S. Liu
摘要
Simultaneously, finding multiple influential variables and controlling the false discovery rate (FDR) for linear regression models is a fundamental problem. We here propose the Gaussian Mirror (GM) method, which creates for each predictor variable a pair of mirror variables by adding and subtracting a randomly generated Gaussian perturbation, and proceeds with a certain regression method, such as the ordinary least-square or the Lasso (the mirror variables can also be created after selection). The mirror variables naturally lead to test statistics effective for controlling the FDR. Under a mild assumption on the dependence among the covariates, we show that the FDR can be controlled at any designated level asymptotically. We also demonstrate through extensive numerical studies that the GM method is more powerful than many existing methods for selecting relevant variables subject to FDR control, especially for cases when the covariates are highly correlated and the influential variables are not overly sparse. *(abstract via OpenAlex)*
SiM Causal Inference Bayesian Methods High-Dimensional · 发表于 2021-06-21
Apostolos Gkatzionis, Stephen Burgess, David V. Conti, Paul J. Newcombe
摘要
Mendelian randomization is the use of genetic variants as instruments to assess the existence of a causal relationship between a risk factor and an outcome. A Mendelian randomization analysis requires a set of genetic variants that are strongly associated with the risk factor and only associated with the outcome through their effect on the risk factor. We describe a novel variable selection algorithm for Mendelian randomization that can identify sets of genetic variants which are suitable in both these respects. Our algorithm is applicable in the context of two‐sample summary‐data Mendelian randomization and employs a recently proposed theoretical extension of the traditional Bayesian statistics framework, including a loss function to penalize genetic variants that exhibit pleiotropic effects. The algorithm offers robust inference through the use of model averaging, as we illustrate by running it on a range of simulation scenarios and comparing it against established pleiotropy‐robust Mendelian randomization methods. In a real‐data application, we study the effect of systolic and diastolic blood pressure on the risk of suffering from coronary heart disease (CHD). Based on a recent large‐scale GWAS for blood pressure, we use 395 genetic variants for systolic and 391 variants for diastolic blood pressure. Both traits are shown to have significant risk‐increasing effects on CHD risk.
JASA Other · 发表于 2021-06-21
Wenxuan Zhong, Yiwen Liu, Peng Zeng
摘要
With rapid advances in information technology, massive datasets are collected in all fields of science, such as biology, chemistry, and social science. Useful or meaningful information is extracted from these data often through statistical learning or model fitting. In massive datasets, both sample size and number of predictors can be large, in which case conventional methods face computational challenges. Recently, an innovative and effective sampling scheme based on leverage scores via singular value decompositions has been proposed to select rows of a design matrix as a surrogate of the full data in linear regression. Analogously, variable screening can be viewed as selecting rows of the design matrix. However, effective variable selection along this line of thinking remains elusive. In this article, we bridge this gap to propose a weighted leverage variable screening method by utilizing both the left and right singular vectors of the design matrix. We show theoretically and empirically that the predictors selected using our method can consistently include true predictors not only for linear models but also for complicated general index models. Extensive simulation studies show that the weighted leverage screening method is highly computationally efficient and effective. We also demonstrate its success in identifying carcinoma related genes using spatial transcriptome data. *(abstract via PubMed)*
SMMR Nonparametric & Semiparametric Survival Analysis Missing Data & Measurement Error · 发表于 2021-06-18
Feng-Chang Lin, Jianwen Cai, Jason P Fine, Elisabeth P Dellon, Charles R Esther
摘要
Proportional rates models are frequently used for the analysis of recurrent event data with multiple event categories. When some of the event categories are missing, a conventional approach is to either exclude the missing data for a complete-case analysis or employ a parametric model for the missing event type. It is well known that the complete-case analysis is inconsistent when the missingness depends on covariates, and the parametric approach may incur bias when the model is misspecified. In this paper, we aim to provide a more robust approach using a rate proportion method for the imputation of missing event types. We show that the log-odds of the event type can be written as a semiparametric generalized linear model, facilitating a theoretically justified estimation framework. Comprehensive simulation studies were conducted demonstrating the improved performance of the semiparametric method over parametric procedures. Multiple types of Pseudomonas aeruginosa infections of young cystic fibrosis patients were analyzed to demonstrate the feasibility of our proposed approach.
SMMR Clinical Trials · 发表于 2021-06-17
Jijia Wang, Jing Cao, Song Zhang, Chul Ahn
摘要
The stepped-wedge cluster randomized design has been increasingly employed by pragmatic trials in health services research. In this study, based on the GEE approach, we present closed-form sample size calculation that is applicable to both closed-cohort and cross-sectional stepped wedge trials. Importantly, the proposed method is flexible to accommodate design issues routinely encountered in pragmatic trials, such as different within- and between-subject correlation structures, irregular crossover schedules for the switch to intervention, and missing data due to repeated measurements over prolonged follow-up. The closed-form formulas allow researchers to analytically assess the impact of different design factors on sample size requirement. We also recognize the potential issue of limited numbers of clusters in pragmatic stepped wedge trials and present an adjustment approach for underestimated variance of the treatment effect. We conduct extensive simulation to assess the performance of the proposed sample size method. An application example to a real clinical trial is presented.
SiM Longitudinal Data Networks & Graphs · 发表于 2021-06-17
Priya Kohli, Xinyu Du, Haoyang Shen
摘要
Joint mean‐covariance modeling of multivariate longitudinal data helps to understand the relative changes among multiple longitudinally measured and correlated outcomes. A key challenge in the analysis of multivariate longitudinal data is the complex covariance structure. This is due to the contemporaneous and cross‐temporal associations between multiple longitudinal outcomes. Graphical and data‐driven tools that can aid in visualizing the dependence patterns among multiple longitudinal outcomes are not readily available. In this work, we show the role of graphical techniques: profile plots, and multivariate regressograms, in developing mean and covariance models for multivariate longitudinal data. We introduce an R packageMLGM(Multivariate Longitudinal Graphical Models) to facilitate visualization and modeling mean and covariance patterns. Through two real studies, microarray data from the T‐cell activation study and Mayo Clinic's primary biliary cirrhosis of the liver study, we show the key features of MLGM. We evaluate the finite sample performance of the proposed mean‐covariance estimation approach through simulations.
SMMR Nonparametric & Semiparametric Testing & Uncertainty · 发表于 2021-06-17
Zhen Meng, Qinglong Yang, Qizhai Li, Baoxue Zhang
摘要
For a nonparametric Behrens-Fisher problem, a directional-sum test is proposed based on division-combination strategy. A one-layer wild bootstrap procedure is given to calculate its statistical significance. We conduct simulation studies with data generated from lognormal, t and Laplace distributions to show that the proposed test can control the type I error rates properly and is more powerful than the existing rank-sum and maximum-type tests under most of the considered scenarios. Applications to the dietary intervention trial further show the performance of the proposed test.
SMMR Meta-Analysis & Data Integration Clinical Trials · 发表于 2021-06-17
Alexander Hodkinson, Evangelos Kontopantelis
摘要
Meta-analysis of clinical trials targeting rare events face particular challenges when the data lack adequate number of events and are susceptible to high levels of heterogeneity. The standard meta-analysis methods (DerSimonian Laird (DL) and Mantel–Haenszel (MH)) often lead to serious distortions because of such data sparsity. Applications of the methods suited to specific incidence and heterogeneity characteristics are lacking, thus we compared nine available methods in a simulation study. We generated 360 meta-analysis scenarios where each considered different incidences, sample sizes, between-study variance (heterogeneity) and treatment allocation. We include globally recommended methods such as inverse-variance fixed/random-effect (IV-FE/RE), classical-MH, MH-FE, MH-DL, Peto, Peto-DL and the two extensions for MH bootstrapped-DL (bDL) and Peto-bDL. Performance was assessed on mean bias, mean error, coverage and power. In the absence of heterogeneity, the coverage and power when combined revealed small differences in meta-analysis involving rare and very rare events. The Peto-bDL method performed best, but only in smaller sample sizes involving rare events. For medium-to-larger sample sizes, MH-bDL was preferred. For meta-analysis involving very rare events, Peto-bDL was the best performing method which was sustained across all sample sizes. However, in meta-analysis with 20% or more heterogeneity, the coverage and power were insufficient. Performance based on mean bias and mean error was almost identical across methods. To conclude, in meta-analysis of rare binary outcomes, our results suggest that Peto-bDL is better in both rare and very rare event settings in meta-analysis with limited sample sizes. However, when heterogeneity is large, the coverage and power to detect rare events are insufficient. Whilst this study shows that some of the less studied methods appear to have good properties under sparse data scenarios, further work is needed to assess them against the more complex distributional-based methods to understand their overall performances.
SiM High-Dimensional Nonparametric & Semiparametric Survival Analysis · 发表于 2021-06-16
Ying Sheng, Yifei Sun, Chiung‐Yu Huang, Mi‐Ok Kim
摘要
Synthesizing external aggregated information has been proven useful in improving estimation efficiency when conducting statistical analysis using a limited amount of data. In this paper, we develop a unified framework for combining information from high‐dimensional individual‐level data and potentially low‐dimensional external aggregate data under the Cox model. We summarize various forms of external aggregated information by population estimating equations and propose a penalized empirical likelihood approach to borrow information from these estimating equations. The proposed methods possess the flexibility to handle the case where individual‐level data and external aggregate data are from heterogeneous populations. Specifically, a penalized empirical likelihood ratio test is developed to check for the potential heterogeneity, and a semiparametric density ratio model is postulated to account for the heterogeneity. Moreover, we study the impact of uncertainty in the auxiliary information on the efficiency gain and propose a modified variance estimator to adjust for the uncertainty. The proposed estimators enjoy the oracle property and are asymptotically more efficient than the penalized partial likelihood estimator that does not exploit the external aggregated information. Simulation studies show improvement in both estimation efficiency and variable selection over the competitors. The proposed approaches are applied to the analysis of a pediatric kidney transplant study for illustration.
SiM Survival Analysis Testing & Uncertainty Nonparametric & Semiparametric · 发表于 2021-06-15
Yongqiang Tang
摘要
The restricted mean survival time (RMST) has been popularly used to assess the treatment effect in survival trials. Greenwood's formula is often used to estimate the variance of RMST, and the resulting Wald confidence interval (CI) tends to be liberal in small and moderate samples. We propose the empirical likelihood ratio, score‐type, and loglog transformed CIs for RMST in a single sample. The method of variance estimates recovery technique is used to derive the CIs for the difference and ratio parameters in the two sample inference. A variance estimate, which assumes equal survival curves, but possibly different censoring rates in the two groups, is proposed for comparing two groups. The new variance estimate shows excellent performance in testing for superiority, and also works well for a noninferiority test with a small margin, and for the interval estimation when the two survival curves are close. We use similar techniques to construct CIs for comparing two milestone survival probabilities. Numerical examples are used to assess these interval estimation methods.
Biometrics Causal Inference · 发表于 2021-06-15
Hao Sun, Ashkan Ertefaie, Brent A. Johnson
摘要
An adaptive treatment length strategy is a sequential stage‐wise treatment strategy where a subject's treatment begins at baseline and one chooses to stop or continue treatment at each stage provided the subject has been continuously treated. The effects of treatment are assumed to be cumulative and, therefore, the effect of treatment length on clinical endpoint, measured at the end of the study, is of primary scientific interest. At the same time, adverse treatment‐terminating events may occur during the course of treatment that require treatment be stopped immediately. Because the presence of a treatment‐terminating event may be strongly associated with the study outcome, the treatment‐terminating event is informative. In observational studies, decisions to stop or continue treatment depend on covariate history that confounds the relationship between treatment length on outcome. We propose a new risk‐set weighted estimator of the mean potential outcome under the condition that time‐dependent covariates update at a set of common landmarks. We show that our proposed estimator is asymptotically linear given mild assumptions and correctly specified working models. Specifically, we study the theoretical properties of our estimator when the nuisance parameters are modeled using either parametric or semiparametric methods. The finite sample performance and theoretical results of the proposed estimator are evaluated through simulation studies and demonstrated by application to the Enhanced Suppression of the Platelet Receptor IIb/IIIa with Integrilin Therapy (ESPRIT) infusion trial data.
SiM Bayesian Methods High-Dimensional · 发表于 2021-06-15
Daniel R. Kowal, Mercedes Bravo, Henry Leong, Alexander Bui, Robert J. Griffin, Katherine B. Ensor, Marie Lynn Miranda
摘要
Social and environmental stressors are crucial factors in child development. However, there exists a multitude of measurable social and environmental factors—the effects of which may be cumulative, interactive, or null. Using a comprehensive cohort of children in North Carolina, we study the impact of social and environmental variables on 4th end‐of‐grade exam scores in reading and mathematics. To identify the essential factors that predict these educational outcomes, we design new tools for Bayesian linear variable selection using decision analysis. We extract a predictive optimal subset of explanatory variables by coupling a loss function with a novel model‐based penalization scheme, which leads to coherent Bayesian decision analysis and empirically improves variable selection, estimation, and prediction on simulated data. The Bayesian linear model propagates uncertainty quantification to all predictive evaluations, which is important for interpretable and robust model comparisons. These predictive comparisons are conducted out‐of‐sample with a customized approximation algorithm that avoids computationally intensive model refitting. We apply our variable selection techniques to identify the joint collection of social and environmental stressors—and their interactions—that offer clear and quantifiable improvements in prediction of reading and mathematics exam scores.
SiM Bayesian Methods High-Dimensional · 发表于 2021-06-14
Himel Mallick, Rahim Alhamzawi, Erina Paul, Vladimir Svetnik
摘要
A reciprocal LASSO (rLASSO) regularization employs a decreasing penalty function as opposed to conventional penalization approaches that use increasing penalties on the coefficients, leading to stronger parsimony and superior model selection relative to traditional shrinkage methods. Here we consider a fully Bayesian formulation of the rLASSO problem, which is based on the observation that the rLASSO estimate for linear regression parameters can be interpreted as a Bayesian posterior mode estimate when the regression parameters are assigned independent inverse Laplace priors. Bayesian inference from this posterior is possible using an expanded hierarchy motivated by a scale mixture of double Pareto or truncated normal distributions. On simulated and real datasets, we show that the Bayesian formulation outperforms its classical cousin in estimation, prediction, and variable selection across a wide range of scenarios while offering the advantage of posterior inference. Finally, we discuss other variants of this new approach and provide a unified framework for variable selection using flexible reciprocal penalties. All methods described in this article are publicly available as an R package at: https://github.com/himelmallick/BayesRecipe.
JASA Other · 发表于 2021-06-14
Yaniv Tenzer, Micha Mandel, Or Zuk
摘要
Testing for dependence between pairs of random variables is a fundamental problem in statistics. In some applications, data are subject to selection bias that can create spurious dependence. An important example is truncation models, in which observed pairs are restricted to a specific subset of the X-Y plane. Standard tests for independence are not suitable in such cases, and alternative tests that take the selection bias into account are required. Here, we generalize the notion of quasi-independence with respect to the sampling mechanism, and study the problem of detecting any deviations from it. We develop two tests statistics motivated by the classic Hoeffding’s statistic, and use two approaches to compute their distribution under the null: (i) a bootstrap-based approach, and (ii) a permutation-test with nonuniform probability of permutations. We also handle an important application to the case of censoring with truncation, by estimating the biased sampling mechanism from the data. We prove the validity of the tests, and show, using simulations, that they improve power compared to competing methods for important special cases. The tests are applied to four datasets, two that are subject to truncation, with and without censoring, and two to bias mechanisms related to length bias. *(abstract via OpenAlex)*
SiM Bayesian Methods Causal Inference Clinical Trials · 发表于 2021-06-14
Meizi Liu, Veronica Bunn, Bradley Hupf, Junjing Lin, Jianchang Lin
摘要
As the availability of real‐world data sources (eg, EHRs, claims data, registries) and historical data has rapidly surged in recent years, there is an increasing interest and need from investigators and health authorities to leverage all available information to reduce patient burden and accelerate both drug development and regulatory decision making. Bayesian meta‐analytic approaches are a popular historical borrowing method that has been developed to leverage such data using robust hierarchical models. The model structure accounts for various degrees of between‐trial heterogeneity, resulting in adaptively discounting the external information in the case of data conflict. In this article, we propose to integrate the propensity score method and Bayesian meta‐analytic‐predictive (MAP) prior to leverage external real‐world and historical data. The propensity score methodology is applied to select a subset of patients from external data that are similar to those in the current study with regards to key baseline covariates and to stratify the selected patients together with those in the current study into more homogeneous strata. The MAP prior approach is used to obtain stratum‐specific MAP prior and derive the overall propensity score integrated meta‐analytic predictive (PS‐MAP) prior. Additionally, we allow for tuning the prior effective sample size for the proposed PS‐MAP prior, which quantifies the amount of information borrowed from external data. We evaluate the performance of the proposed PS‐MAP prior by comparing it to the existing propensity score‐integrated power prior approach in a simulation study and illustrate its implementation with an example of a single‐arm phase II trial.
SMMR Spatial & Time Series Testing & Uncertainty · 发表于 2021-06-14
Chun Yin Lee
摘要
The area under the receiver operating characteristic curve (AUC) is one of the most popular measures for evaluating the performance of a predictive model. In nested models, the change in AUC (ΔAUC) can be a discriminatory measure of whether the newly added predictors provide significant improvement in terms of predictive accuracy. Recently, several authors have shown rigorously that ΔAUC can be degenerate and its asymptotic distribution is no longer normal when the reduced model is true, but it could be the distribution of a linear combination of some [Formula: see text] random variables [ 1 , 2 ]. Hence, the normality assumption and existing variance estimate cannot be applied directly for developing a statistical test under the nested models. In this paper, we first provide a brief review on the use of ΔAUC for comparing nested logistic models and the difficulty of retrieving the reference distribution behind. Then, we present a special case of the nested logistic regression models that the newly added predictor to the reduced model contains a change-point in its effects. A new test statistic based on ΔAUC is proposed in this setting. A simple resampling scheme is proposed to approximate the critical values for the test statistic. The inference of the change-point parameter is done via m-out-of- n bootstrap. Large-scale simulation is conducted to evaluate the finite-sample performance of the ΔAUC test for the change-point model. The proposed method is applied to two real-life datasets for illustration.
SiM Clinical Trials · 发表于 2021-06-14
Victor B. Talisa, Chung‐Chou H. Chang
摘要
Clinical trials require substantial effort and time to complete, and regulatory agencies may require two successful efficacy trials before approving a new drug. One way to improve the chance of follow‐up success is to identify a subpopulation among whom treatment effects are estimated to be beneficial, and enrolling future studies from this subpopulation. In this article we studyconfirmable responder class (CRC)learning, where the objective is to learn in a random half of the dataset (training set) a subpopulation among whom the predicted conditional ATE (CATE) suggests clinically meaningful benefit, with maximum power of being confirmed via hypothesis test in the other half (test set). We studied a set of CRC learners across simulated datasets in which either all patients benefited, or only some did. Performance metrics included the rate of confirmation in the test set, and the classification accuracy of the CRC compared with the group with true CATE>0. In trials where all patients benefitted, only two learners were able to consistently identify most of the population as the CRC. One of these also performed especially well when only some patients benefitted, having relatively high confirmation rates, and showing robustness to the dimension of the covariate vector and population characteristics. This learner is based on cross‐validation, and is a possible avenue for further development of model selection criteria for CRC learning. We also show that the performance of all methods can be improved by using both halves of the original dataset as training and test sets in turn.
JASA High-Dimensional Testing & Uncertainty · 发表于 2021-06-14
Zhenhua Lin, Miles E. Lopes, Hans-Georg Müller
摘要
We propose a new approach to the problem of high-dimensional multivariate ANOVA via bootstrapping max statistics that involve the differences of sample mean vectors. The proposed method proceeds via the construction of simultaneous confidence regions for the differences of population mean vectors. It is suited to simultaneously test the equality of several pairs of mean vectors of potentially more than two populations. By exploiting the variance decay property that is a natural feature in relevant applications, we are able to provide dimension-free and nearly parametric convergence rates for Gaussian approximation, bootstrap approximation, and the size of the test. We demonstrate the proposed approach with ANOVA problems for functional data and sparse count data. The proposed methodology is shown to work well in simulations and several real data applications. *(abstract via OpenAlex)*
SiM Other · 发表于 2021-06-14
Frank Konietschke, Cong Cao, Asanka Gunawardana, Georg Zimmermann
摘要
Adjusting for baseline values and covariates is a recurrent statistical problem in medical science. In particular, variance heteroscedasticity is non‐negligible in experimental designs and ignoring it might result in false conclusions. Approximate inference methods are developed to test null hypotheses formulated in terms of adjusted treatment effects and regression parameters in general analysis of covariance designs with arbitrary numbers of factors. Variance homoscedasticity is not assumed. The distributions of the test statistics are approximated using Box‐type approximation methods. Extensive simulation studies show that the procedures are particularly suitable when sample sizes are rather small. A real data set illustrates the application of the methods.
SiM Clinical Trials Testing & Uncertainty · 发表于 2021-06-14
Duncan T. Wilson, Julia Brown, Amanda J. Farrin, Rebecca E. A. Walwyn
摘要
The power of a large clinical trial can be adversely affected by low recruitment, follow‐up, and adherence rates. External pilot trials estimate these rates and use them, via prespecified decision rules, to determine if the definitive trial is feasible and should go ahead. There is little methodological research underpinning how these decision rules, or the sample size of the pilot, should be chosen. In this article we propose a hypothesis test of the feasibility of a definitive trial, to be applied to the external pilot data and used to make progression decisions. We quantify feasibility by the power of the planned trial, as a function of recruitment, follow‐up, and adherence rates. We use this measure to define hypotheses to test in the pilot, propose a test statistic, and show how the error rates of this test can be calculated for the common scenario of a two‐arm parallel group definitive trial with a single normally distributed primary endpoint. We use our method to redesign TIGA‐CUB, an external pilot trial comparing a psychotherapy with treatment as usual for children with conduct disorders. We then extend our formulation to include using the pilot data to estimate the standard deviation of the primary endpoint and incorporate this into the progression decision.
SiM Survival Analysis Diagnostics & Prediction Nonparametric & Semiparametric · 发表于 2021-06-14
Krithika Suresh, Jeremy M.G. Taylor, Alexander Tsodikov
摘要
Dynamic prediction methods incorporate longitudinal biomarker information to produce updated, more accurate predictions of conditional survival probability. There are two approaches for obtaining dynamic predictions: (1) a joint model of the longitudinal marker and survival process, and (2) an approximate approach that specifies a model for a specific component of the joint distribution. In the case of a binary marker, an illness‐death model is an example of a joint modeling approach that is unified and produces consistent predictions. However, previous literature has shown that approximate approaches, such as landmarking, with additional flexibility can have good predictive performance. One such approach proposes using a Gaussian copula to model the joint distribution of conditional continuous marker and survival distributions. It has the advantage of specifying established, flexible models for the marginals for which goodness‐of‐fit can be assessed, and has easy estimation that can be implemented in standard software. In this article, we provide a Gaussian copula approach for dynamic prediction to accommodate a binary marker using a continuous latent variable formulation. We compare the predictive performance of this approach to joint modeling and landmarking using simulations and demonstrate its use for obtaining dynamic predictions in an application to a prostate cancer study.
Biometrics Clinical Trials · 发表于 2021-06-13
Jianghao Li, Sin‐Ho Jung
摘要
We propose group sequential methods for cluster randomized trials (CRTs) with time‐to‐event endpoint. The alpha spending function approach is used for sequential data monitoring. The key to this approach is determining the joint distribution of test statistics and the information fraction at the time of interim analysis. We prove that the sequentially computed log‐rank statistics in CRTs do not have independent increment property. We also propose an information fraction for group sequential trials with clustered survival data and a corresponding sample size determination approach. Extensive simulation studies are conducted to evaluate the performance of our proposed testing procedure using some existing alpha spending functions in terms of expected sample size and maximal sample size. Real study examples are taken to demonstrate our method.
SiM Clinical Trials Econometrics & Economics · 发表于 2021-06-13
Ivair R. Silva, Judith Maro, Martin Kulldorff
摘要
In sequential analysis, hypothesis testing is performed repeatedly in a prospective manner as data accrue over time to quickly arrive at an accurate conclusion or decision. In this tutorial paper, detailed explanations are given for both designing and operating sequential testing. We describe the calculation of exact thresholds for stopping or signaling, statistical power, expected time to signal, and expected sample sizes for sequential analysis with Poisson and binary type data. The calculations are run using the packageSequential, constructed inRlanguage. Real data examples are inspired on clinical trials practice, such as the current efforts to develop treatments to face the COVID‐19 pandemic, and the comparison of treatments of osteoporosis. In addition, we mimic the monitoring of adverse events following influenza vaccination and Pediarix vaccination.
SiM Other · 发表于 2021-06-11
Yuxin Zhu, Zheyu Wang, Ava L. Liberman, Tzu‐Pu Chang, David Newman‐Toker
摘要
In longitudinal event data, a crude rate is a simple quantification of the event rate, defined as the number of events during an evaluation window, divided by the at‐risk population size at the beginning or mid‐time point of that window. The crude rate recently received revitalizing interest from medical researchers who aimed to improve measurement of misdiagnosis‐related harms using administrative or billing data by tracking unexpected adverse events following a “benign” diagnosis. The simplicity of these measures makes them attractive for implementation and routine operational monitoring at hospital or health system level. However, relevant statistical inference procedures have not been systematically summarized. Moreover, it is unclear to what extent the temporal changes of the at‐risk population size would bias analyses and affect important conclusions concerning misdiagnosis‐related harms. In this article, we present statistical inference tools for using crude‐rate based harm measures, as well as formulas and simulation results that quantify the deviation of such measures from those based on the more sophisticated Nelson‐Aalen estimator. Moreover, we present results for a generalized multibin version of the crude rate, for which the usual crude rate is a single‐bin special case. The generalized multibin crude rate is more straightforward to compute than the Nelson‐Aalen estimator and can reduce potential biases of the single‐bin crude rate. For studies that seek to use multibin measures, we provide simulations to guide the choice regarding number of bins. We further bolster these results using a worked example of stroke after “benign” dizziness from a large data set.
SiM Longitudinal Data Survival Analysis Bayesian Methods · 发表于 2021-06-11
Danilo Alvares, Francisco J. Rubio
摘要
We introduce a numerically tractable formulation of Bayesian joint models for longitudinal and survival data. The longitudinal process is modeled using generalized linear mixed models, while the survival process is modeled using a parametric general hazard structure. The two processes are linked by sharing fixed and random effects, separating the effects that play a role at the time scale from those that affect the hazard scale. This strategy allows for the inclusion of nonlinear and time‐dependent effects while avoiding the need for numerical integration, which facilitates the implementation of the proposed joint model. We explore the use of flexible parametric distributions for modeling the baseline hazard function which can capture the basic shapes of interest in practice. We discuss prior elicitation based on the interpretation of the parameters. We present an extensive simulation study, where we analyze the inferential properties of the proposed models, and illustrate the trade‐off between flexibility, sample size, and censoring. We also apply our proposal to two real data applications in order to demonstrate the adaptability of our formulation both in univariate time‐to‐event data and in a competing risks framework. The methodology is implemented inrstan.
SiM Other · 发表于 2021-06-10
Ana M. Ortega‐Villa, Martha C. Nason, Dean Follmann
摘要
Repeated low‐dose challenge studies provide valuable information when evaluating candidate vaccines since they resemble the typical exposure of natural transmission and inform on the number of exposures prior to infection. Traditionally, the number of challenges to infection has been used as the outcome. This work uses the number of infecting viruses, or founder viruses at the time of infection, to more efficiently characterize a vaccine's mechanism of action. The vaccine mechanisms of action we consider are a Null mechanism (the vaccine offers no protection), a Leaky mechanism in which the number of founder viruses is reduced by some factor in vaccinated subjects, the All‐or‐None mechanism in which the vaccine randomly provides either complete protection or no protection in vaccinated subjects, and a Combination mechanism with both Leaky and All‐or‐None components. We consider two discrete marked survival models where the number of founder viruses follows a Poisson distribution with either a fixed mean parameter (Poisson model), or a random mean parameter that follows a Gamma distribution (negative binomial model). We estimate the models using maximum likelihood and derive likelihood ratio testing procedures that are accurate for small samples with boundary parameters. We illustrate the performance of these methodologies with a data example of simian immunodeficiency virus on nonhuman primates and a simulation study.
SiM Survival Analysis Causal Inference · 发表于 2021-06-10
An‐Shun Tai, Chun‐An Tsai, Sheng‐Hsuan Lin
摘要
In medical research, the development of mediation analysis with a survival outcome has facilitated investigation into causal mechanisms. However, studies have not discussed the death‐truncation problem for mediators, the problem being that conventional mediation parameters cannot be well defined in the presence of a truncated mediator. In the present study, we systematically defined the completeness of causal effects to uncover the gap, in conventional causal definitions, between the survival and nonsurvival settings. We propose a novel approach to redefining natural direct and indirect effects, which are generalized forms of conventional causal effects for survival outcomes. Furthermore, we developed three statistical methods for the binary outcome of survival status and formulated a Cox model for survival time. We performed simulations to demonstrate that the proposed methods are unbiased and robust. We also applied the proposed method to explore the effect of hepatitis C virus infection on mortality, as mediated through hepatitis B viral load.
SMMR Survival Analysis Missing Data & Measurement Error · 发表于 2021-06-10
Yoshinori Takeuchi, Mitsunori Ogawa, Yasuhiro Hagiwara, Yutaka Matsuyama
摘要
In clinical and epidemiological studies using survival analysis, some explanatory variables are often missing. When this occurs, multiple imputation (MI) is frequently used in practice. In many cases, simple parametric imputation models are routinely adopted without checking the validity of the model specification. Misspecified imputation models can cause biased parameter estimates. In this study, we describe novel frequentist type MI procedures for survival analysis using proportional and additive hazards models. The procedures are based on non-parametric estimation techniques and do not require the correct specification of parametric imputation models. For continuous missing covariates, we first sample imputation values from a parametric imputation model. Then, we obtain estimates by solving the estimating equation modified by non-parametrically estimated conditional densities. For categorical missing covariates, we directly sample imputation values from a non-parametrically estimated conditional distribution and then obtain estimates by solving the corresponding estimating equation. We evaluate the performance of the proposed procedures using simulation studies: one uses simulated data; another uses data informed by parameters generated from a real-world medical claims database. We also applied the procedures to a pharmacoepidemiological study that examined the effect of antihyperlipidemics on hyperglycemia incidence.
SiM Causal Inference Econometrics & Economics · 发表于 2021-06-10
An‐Shun Tai, Sheng‐Hsuan Lin
摘要
Recent methodological developments in causal mediation analysis have addressed several issues regarding multiple mediators. However, these developed methods differ in their definitions of causal parameters, assumptions for identification, and interpretations of causal effects, making it unclear which method ought to be selected when investigating a given causal effect. Thus, in this study, we construct an integrated framework, which unifies all existing methodologies, as a standard for mediation analysis with multiple mediators. To clarify the relationship between existing methods, we propose four strategies for effect decomposition: two‐way, partially forward, partially backward, and complete decompositions. This study reveals how the direct and indirect effects of each strategy are explicitly and correctly interpreted as path‐specific effects under different causal mediation structures. In the integrated framework, we further verify the utility of the interventional analogues of direct and indirect effects, especially when natural direct and indirect effects cannot be identified or when crossworld exchangeability is invalid. Consequently, this study yields a robustness‐specificity trade‐off in the choice of strategies. Inverse probability weighting is considered for estimation. The four strategies are further applied to a simulation study for performance evaluation and for analyzing the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer dataset from Taiwan to investigate the causal effect of hepatitis C virus infection on mortality.
SiM Testing & Uncertainty Longitudinal Data · 发表于 2021-06-10
Baoyi Shi, R. Todd Ogden
摘要
In a function‐on‐scalar regression framework, we present some modeling strategies for functional mixed models and also some approaches for making inference about various aspects of the fixed effects. This is presented in the context of modeling positron emission tomography (PET) data in order to explore the density of various proteins of interest throughout the human brain. For this application, information about the density of the target protein in a given brain region is encapsulated in theimpulse response function(IRF) of the region. Previous work on nonparametric estimation of the IRF is limited in that it is only able to model a single brain region at a time. We propose an extension, based on principles of functional data analysis, that will allow modeling of multiple brain regions simultaneously. Applicable more broadly to functional mixed regression modeling, we discuss two general approaches for permutation testing and describe valid strategies for identifying exchangeable units within the model and building corresponding permutation tests. We illustrate our methods with an application to PET data and explore the effects of depression and sex on the IRF.
SMMR Meta-Analysis & Data Integration Clinical Trials · 发表于 2021-06-10
Elena Kulinskaya, David C. Hoaglin, Ilyas Bakbergenuly
摘要
Contemporary statistical publications rely on simulation to evaluate performance of new methods and compare them with established methods. In the context of random-effects meta-analysis of log-odds-ratios, we investigate how choices in generating data affect such conclusions. The choices we study include the overall log-odds-ratio, the distribution of probabilities in the control arm, and the distribution of study-level sample sizes. We retain the customary normal distribution of study-level effects. To examine the impact of the components of simulations, we assess the performance of the best available inverse–variance–weighted two-stage method, a two-stage method with constant sample-size-based weights, and two generalized linear mixed models. The results show no important differences between fixed and random sample sizes. In contrast, we found differences among data-generation models in estimation of heterogeneity variance and overall log-odds-ratio. This sensitivity to design poses challenges for use of simulation in choosing methods of meta-analysis.
SiM Causal Inference Survival Analysis Machine Learning · 发表于 2021-06-10
Liangyuan Hu, Jiayi Ji, Fan Li
摘要
Methods for estimating heterogeneous treatment effect in observational data have largely focused on continuous or binary outcomes, and have been relatively less vetted with survival outcomes. Using flexible machine learning methods in the counterfactual framework is a promising approach to address challenges due to complex individual characteristics, to which treatments need to be tailored. To evaluate the operating characteristics of recent survival machine learning methods for the estimation of treatment effect heterogeneity and inform better practice, we carry out a comprehensive simulation study presenting a wide range of settings describing confounded heterogeneous survival treatment effects and varying degrees of covariate overlap. Our results suggest that the nonparametric Bayesian Additive Regression Trees within the framework of accelerated failure time model (AFT‐BART‐NP) consistently yields the best performance, in terms of bias, precision, and expected regret. Moreover, the credible interval estimators from AFT‐BART‐NP provide close to nominal frequentist coverage for the individual survival treatment effect when the covariate overlap is at least moderate. Including a nonparametrically estimated propensity score as an additional fixed covariate in the AFT‐BART‐NP model formulation can further improve its efficiency and frequentist coverage. Finally, we demonstrate the application of flexible causal machine learning estimators through a comprehensive case study examining the heterogeneous survival effects of two radiotherapy approaches for localized high‐risk prostate cancer.
SiM Clinical Trials · 发表于 2021-06-10
Tianyu Zhan, Lu Cui, Ziqian Geng, Lanju Zhang, Yihua Gu, Ivan S.F. Chan
摘要
Response adaptive randomization (RAR) is appealing from methodological, ethical, and pragmatic perspectives in the sense that subjects are more likely to be randomized to better performing treatment groups based on accumulating data. However, applications of RAR in confirmatory drug clinical trials with multiple active arms are limited largely due to its complexity, and lack of control of randomization ratios to different treatment groups. To address the aforementioned issues, we propose a Response Adaptive Block Randomization (RABR) design allowing arbitrarily prespecified randomization ratios for the control and high‐performing groups to meet clinical trial objectives. We show the validity of the conventional unweighted test in RABR with a controlled type I error rate based on the weighted combination test for sample size adaptive design invoking no large sample approximation. The advantages of the proposed RABR in terms of robustly reaching target final sample size to meet regulatory requirements and increasing statistical power as compared with the popular Doubly Adaptive Biased Coin Design are demonstrated by statistical simulations and a practical clinical trial design example.
Biometrics Spatial & Time Series Latent Variables & Mixtures Survey & Sampling · 发表于 2021-06-08
Ben C. Stevenson, Rachel M. Fewster, Koustubh Sharma
摘要
Spatial capture–recapture (SCR) models are commonly used to estimate animal density from surveys on which detectors passively detect animals without physical capture, for example, using camera traps, hair snares, or microphones. An individual is more likely to be recorded by detectors close to its activity center, the centroid of its movement throughout the survey. Existing models to account for this spatial heterogeneity in detection probabilities rely on an assumption of independence between detection records at different detectors conditional on the animals' activity centers, which are treated as latent variables. In this paper, we show that this conditional independence assumption may be violated due to the way animals move around the survey region and encounter detectors, such that additional spatial correlation is almost inevitable. We highlight the links between the well‐studied issue of unmodeled temporal heterogeneity in nonspatial capture–recapture and this variety of unmodeled spatial heterogeneity in SCR, showing that the latter causes predictable bias in the same way as the former. We address this by introducing a latent detection field into the model, and illustrate the resulting approach with a simulation study and an application to a camera‐trap survey of snow leopards Panthera uncia. Our method is a unifying model for several existing SCR approaches, with special cases including standard SCR, models that account for nonspatial individual heterogeneity, and models with overdispersed detection counts.
Biometrics Clinical Trials · 发表于 2021-06-08
Lu Mao, KyungMann Kim, Xinran Miao
摘要
Originally proposed for the analysis of prioritized composite endpoints, the win ratio has now expanded into a broad class of methodology based on general pairwise comparisons. Complicated by the non‐i.i.d. structure of the test statistic, however, sample size estimation for the win ratio has lagged behind. In this article, we develop general and easy‐to‐use formulas to calculate sample size for win ratio analysis of different outcome types. In a nonparametric setting, the null variance of the test statistic is derived using U ‐statistic theory in terms of a dispersion parameter called the standard rank deviation, an intrinsic characteristic of the null outcome distribution and the user‐defined rule of comparison. The effect size can be hypothesized either on the original scale of the population win ratio, or on the scale of a “usual” effect size suited to the outcome type. The latter approach allows one to measure the effect size by, for example, odds/continuation ratio for totally/partially ordered outcomes and hazard ratios for composite time‐to‐event outcomes. Simulation studies show that the derived formulas provide accurate estimates for the required sample size across different settings. As illustration, real data from two clinical studies of hepatic and cardiovascular diseases are used as pilot data to calculate sample sizes for future trials.
SiM Clinical Trials · 发表于 2021-06-08
John Lawrence
摘要
To extend marketing exclusivity, a drug manufacture is required by the Food and Drug Administration to conduct an interpretable study of approved drugs that may benefit pediatric patients. In return for conducting an interpretable study, the drug manufacturer is rewarded with an additional 6 months of marketing exclusivity. If the study design uses a fixed sample size and nothing is changed during the study, it is relatively easy to determine whether an interpretable study was conducted. However, if the sample size can be changed based on an unblinded interim analysis, it is difficult to answer the question of whether the study was interpretable. We investigate the optimal design from the manufacturers perspective and find the strategy for sample size adaptation that optimizes the utility including the chance of an interpretable study.
JASA Other · 发表于 2021-06-08
not listed
摘要
In this issue, you will find the following articles that Journal of the American Statistical Association intended to publish in the March 2021 special issue, Theory and Methods Special Issue on Pre... *(abstract via OpenAlex)*
Biometrics Causal Inference Clinical Trials · 发表于 2021-06-08
Bo Zhang, Siyu Heng, Emily J. MacKay, Ting Ye
摘要
Instrumental variable (IV) methods are widely used in medical research to draw causal conclusions when the treatment and outcome are confounded by unmeasured confounding variables. One important feature of such studies is that the IV is often applied at the cluster level, for example, hospitals' or physicians' preference for a certain treatment where each hospital or physician naturally defines a cluster. This paper proposes to embed such observational IV data into a cluster‐randomized encouragement experiment using nonbipartite matching. Potential outcomes and causal assumptions underpinning the design are formalized and examined. Testing procedures for two commonly used estimands, Fisher's sharp null hypothesis and the pooled effect ratio (PER), are extended to the current setting. We then introduce a novel cluster‐heterogeneous proportional treatment effect model and the relevant estimand: the average cluster effect ratio. This new estimand is advantageous over the structural parameter in a constant proportional treatment effect model in that it allows treatment heterogeneity, and is advantageous over the PER estimand in that it does not suffer from Simpson's paradox. We develop an asymptotically valid randomization‐based testing procedure for this new estimand based on solving a mixed‐integer quadratically constrained optimization problem. The proposed design and inferential methods are applied to a study of the effect of using transesophageal echocardiography during coronary artery bypass graft surgery on patients' 30‐day mortality rate. R package ivdesign implements the proposed method.